"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...
Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...
Hosted on MSN13h
We Asked Retail Traders About Eli Lilly’s Biggest Post-Q4 Risk — Most Say It’s The Weight-Loss Drug WarsShares of Eli Lilly finished Thursday 3% higher despite an earnings report that showed sales of its blockbuster GLP-1 ...
As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scala asked CEO David Ricks if the company ...
Eli Lilly, BCE, Suncor, Canada Goose, Bombardier, Thomson Reuters and Lightspeed reported earnings this week. Here are the details for Canadian investors.
Evaluate’s latest analysis forecasts an $82 billion increase in major product revenues in 2025 – the largest annual growth ...
Medical Center Hospital is celebrating 200 successful open-heart surgeries in 2024. The Beat Goes On will take place from 4 p ...
While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.
The Midland Health Drive Thru Testing Clinic saw 30 patients Feb. 7 with a 26% positivity rate. The clinic will be testing Feb. 8 from 9 a.m. to 1 p.m. In addition, the clinic will be open next week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback